The History and Development of Sildenafil Citrate

Alfuzosin: (Moderate) Due to the potential for symptomatic hypotension, patients should be stable on alfuzosin therapy before initiating therapy with the lowest dose of sildenafil.

• Sildenafil citrate can also treat pulmonary arterial hypertension.
• It enhances exercise capacity in patients with this condition.
• The drug’s effects usually last 4-6 hours.
• Taking it with a high-fat meal can delay absorption.
• Sildenafil should not be used with nitrate medications.
• Serious side effects include vision changes and priapism.
• It is contraindicated in individuals with certain heart conditions.
• Patients should inform their doctor about all medications.

Conversely, patients already receiving an optimized dose of sildenafil should be started on the lowest dose of alfuzosin; increases in the alpha-blocker dose should be done in a stepwise fashion.

• Sildenafil works by inhibiting phosphodiesterase type 5 enzyme.
• This inhibition increases cGMP levels in the body.
• Elevated cGMP leads to smooth muscle relaxation.
• It promotes vasodilation in the corpus cavernosum.
• This process facilitates an erection during sexual activity.
• The drug’s pharmacokinetics allow for rapid absorption.
• Food intake can influence absorption rate.
• It is effective in men of various ages.

Other variables, such as intravascular volume depletion, concurrent antihypertensive therapy, or evidence of hemodynamic instability with alpha-blocker monotherapy, may affect the safety of concomitant use of sildenafil and alfuzosin.

Further information

The dose was gradually titrated up to 2 mg/kg/dose IV based on clinical response. For doses less than 1.5 mg/kg/dose IV, the infusion time was gradually decreased to over 1 hour (weaned by 1 hour every 36 to 48 hours). The third neonate (gestational age 25 weeks, postnatal age 18.6 weeks) was receiving oral sildenafil 1.67 mg/kg/dose PO every 6 hours and was converted to sildenafil 1.25 mg/kg/dose IV every 6 hours when she became "nothing-by-mouth" (NPO) status. All 3 neonates were also receiving inhaled nitric oxide at the time of sildenafil initiation. The duration of treatment ranged from 6 to 51 days, and respiratory support was able to be decreased over time in all patents.

Raynaud's phenomenon

Hepatic dosing adjustments for adults with erectile dysfunction:Consider a starting dose of 25 mg in adults with any degree of hepatic impairment.Hepatic dosing adjustments for patients with pulmonary hypertension:No adjustment needed for adults with mild to moderate hepatic impairment (Child Pugh class A or B). The effect of severe hepatic impairment (Child Pugh class C) has not been studied. Specific guidelines for pediatric patients are not available. Renal dosing adjustments for adults with erectile dysfunction:CrCl 30 mL/minute or greater: No dosage adjustment is needed.CrCl less than 30 mL/minute: Reducing starting dose to 25 mg PO.Renal dosing adjustments for patients with pulmonary hypertension:No adjustment needed for adults with renal impairment, including adults with severe renal impairment (CrCl less than 30 mL/minute). Specific guidelines for pediatric patients are not available.Intermittent hemodialysisFollow recommendations for patients with CrCl less than 30 mL/minute. Aliskiren: (Moderate) Aliskiren can enhance the effects of sildenafil on blood pressure if given concomitantly. This additive effect may be desirable, but dosages must be adjusted accordingly.

Product	Dosage	Quantity + Bonus	Price
Viagra Generic	50mg	120 + 6 Pills	129.64€ 123.47€	Buy
Viagra Generic	100mg	30 + 4 Pills	60.91€ 58.01€	Buy
Viagra Generic	150mg	60 + 4 Pills	111.25€ 105.95€	Buy
Kamagra Oral Jelly	100mg	63 + 7 Sachets	224.18€ 213.50€	Buy
Kamagra Polo	100mg	20 Pills	83.56€ 79.58€	Buy
Viagra Generic	150mg	120 + 8 Pills	177.58€ 169.12€	Buy
Kamagra Polo	100mg	120 + 6 Pills	327.15€ 311.57€	Buy
Viagra Generic	200mg	10 Pills	40.96€ 39.01€	Buy
Viagra Generic	100mg	20 Pills	45.58€ 43.41€	Buy
Viagra Generic	25mg	360 + 10 Pills	213.68€ 203.50€	Buy

Blood pressure and electrolytes should be routinely monitored in patients receiving aliskiren.

Pregnancy & Lactation

Sildenafil therapy may be an alternative therapy in patients with Raynaud's resistant to vasodilatory therapy. 50 mg PO every 8 hours starting the day before ascent and continuing for 5 days after reaching the target altitude or until descent is initiated as an alternative to nifedipine. Prophylactic medications should only be considered for individuals with a prior history of high altitude pulmonary edema. Delay use in extremely premature infants until retinal vascularization is established. The pharmacokinetics of sildenafil are highly variable in neonates; careful dose titration and monitoring is recommended.

Sildenafil Oral Film for ED

Prior to the release of pediatric pulmonary hypertension guidelines, the generally accepted dose of sildenafil was 0.5 to 2 mg/kg/dose every 6 to 8 hours, with doses ranging up to 3 mg/kg/dose every 6 hours ; however, guidelines recommend more conservative dosing based on a greater risk of mortality in pediatric patients (age 1 to 17 years) treated with high dose sildenafil monotherapy, as seen in the STARTS-2 trial. Relevance of this data to the neonatal population is unclear. 0.4 mg/kg IV loading dose over 3 hours followed by a continuous infusion of 0.067 mg/kg/hour (1.6 mg/kg/day); this dose has been proposed based sildenafil pricing on the results of an open-label, dose-escalation study in 36 term neonates. Very limited data are available; intermittent IV infusions have been used when oral intake was not possible in 3 neonates. An initial dosage of 0.4 to 0.5 mg/kg/dose IV every 6 hours (infused over 3 hours) was given to 2 term neonates with pulmonary hypertension secondary to congenital diaphragmatic hernia. Aliskiren; Hydrochlorothiazide, HCTZ: (Moderate) Aliskiren can enhance the effects of sildenafil on blood pressure if given concomitantly.

2 Answers 2

May increase the dose up to 100 mg PO as needed approximately 1 hour before sexual activity. Dose may be titrated as needed based on symptoms and tolerability to a maximum of 80 mg PO 3 times daily. Although dose-response improvement in exercise ability was not observed in short-term clinical trials in adults with pulmonary hypertension, the delay in clinical worsening with long-term use of sildenafil in a clinical trial supports dosing up to a maximum of 80 mg PO 3 times daily. A maximum dose in pediatric patients has not been identified. Based on experience in adults, the dose may be titrated as needed to a maximum of 40 mg PO 3 times daily based on symptoms and tolerability.

How does sildenafil work (mechanism of action)?

Avoid higher dosing due to a greater risk of mortality in pediatric patients (age 1 to 17 years) treated with high dose sildenafil monotherapy. 0.5 to 1 mg/kg/dose PO every 8 hours. Prior to the release of pediatric pulmonary hypertension guidelines, the generally accepted dose of sildenafil was 0.5 to 2 mg/kg/dose every 6 to 8 hours, with some regimens, particularly those described in earlier reports, administering doses every 4 hours; however, guidelines recommend more conservative dosing based on a greater risk of mortality in pediatric patients (age 1 to 17 years) treated with high dose sildenafil monotherapy, as seen in the STARTS-2 trial. Relevance of this data to the infant population is unclear. 0.22 to 0.5 mg/kg/dose PO as a single dose 1 hour prior to discontinuing iNO or 4 times daily. Alpha-blockers: (Moderate) Due to the potential for symptomatic hypotension, patients should be stable on alpha-blocker therapy before initiating therapy with the lowest dose of sildenafil.

How should this medicine be used?

None of canada sildenafil the 15 patients receiving a single sildenafil dose of 0.3 to 0.5 mg/kg/dose PO 1 hour prior to discontinuation of iNO experienced rebound pulmonary hypertension compared to 10 of 14 patients receiving placebo. In 7 patients receiving sildenafil 0.22 to 0.47 mg/kg/dose PO 4 times daily, mean iNO dose was significantly reduced compared to baseline within 24 hours of sildenafil initiation (12.2 vs. 29.8 ppm, p = 0.024). Guidelines recommend sildenafil use to prevent rebound pulmonary hypertension and facilitate iNO weaning in patients with evidence of increased pulmonary artery pressure upon iNO withdrawal; however, they do not provide specific dosing. Recommended maintenance dosing for pulmonary hypertension is 0.5 to 1 mg/kg/dose PO 3 times daily in persons younger than 1 year, 10 mg PO 3 times daily in persons weighing 20 kg or less, and 20 mg PO 3 times daily in persons weighing more than 20 kg.

Mécanisme d'action

A double-blind, placebo-controlled, crossover study evaluated sildenafil for symptomatic secondary Raynaud's phenomenon resistant to vasodilatory therapy. Patients (n = 18, 15 were female) were randomly assigned to receive placebo or sildenafil 50 mg PO twice daily for 4 weeks; a washout period of 1 week was used before crossover. The results showed that sildenafil significantly improved microcirculation and symptoms associated with Raynaud's. In patients with chronic digital ulcerations, sildenafil treatment resulted in healing of trophic lesions which reappeared or progressed when sildenafil was stopped. Ulcerations did not heal while receiving placebo. Conversely, patients already receiving an optimized dose of sildenafil should be started on the lowest dose of the alpha-blocker; increases in the alpha-blocker dose should be done in a stepwise fashion.

What special precautions should I follow?

A decreased pressor effect of phenylephrine might occur. Monitor for proper blood pressure when these drugs are used together. Acetaminophen; Dextromethorphan; Guaifenesin; Phenylephrine: (Minor) The therapeutic effect of phenylephrine injection may be decreased in patients receiving phosphodiesterase inhibitors. Acetaminophen; Dextromethorphan; Phenylephrine: (Minor) The sildenafil pink pill therapeutic effect of phenylephrine injection may be decreased in patients receiving phosphodiesterase inhibitors. Acetaminophen; Guaifenesin; Phenylephrine: (Minor) The therapeutic effect of phenylephrine injection may be decreased in patients receiving phosphodiesterase inhibitors.

Hazard Classifications

Acetaminophen; Phenylephrine: (Minor) The therapeutic effect of phenylephrine injection may be decreased in patients receiving phosphodiesterase inhibitors. Adagrasib: (Major) Coadministration with adagrasib is not recommended in patients receiving sildenafil for pulmonary arterial hypertension (PAH). When sildenafil is used for erectile dysfunction, consider a starting dose of 25 mg for patients receiving adagrasib. Concurrent use may increase sildenafil plasma concentrations resulting in increased associated adverse events including hypotension, syncope, visual changes, and prolonged erection. Coadministration of other strong CYP3A inhibitors increased the sildenafil AUC between 3- and 11-fold. Other variables, such as intravascular volume depletion, concurrent antihypertensive therapy, or evidence of hemodynamic instability with alpha-blocker monotherapy, may affect the safety of concomitant use of sildenafil and an alpha-blocker.

Condition	Temperature Range	Light Exposure	Additional Notes
General storage	20-25°C (68-77°F)	Keep in original container	Avoid moisture and heat
Refrigeration	Not required	No	If needed, store in fridge
Avoid exposure	Humidity, direct sunlight	Yes	To preserve potency

Ambrisentan: (Moderate) Although no specific interactions have been documented, ambrisentan has vasodilatory effects and may contribute additive hypotensive effects when given with other antihypertensive agents.

Effect	Mechanism	Onset Time	Duration
Vasodilation	Increased cGMP in smooth muscle	30 mins	4-6 hours
Blood Pressure Reduction	Vasodilation effects	Rapid	Several hours
Enhanced Erectile Function	Increased blood flow to penis	30 mins	Up to 4-6 hours

Patients receiving ambrisentan in combination with other antihypertensive agents should be monitored for decreases in blood pressure.

Parameter	Value	Description	Notes
Absorption	Rapid	Peak plasma levels in 30-120 mins	After oral administration
Bioavailability	40%	Percentage of dose reaching systemic circulation	Subject to food effects
Half-life	4 hours	Time for plasma concentration to reduce by half	---
Metabolism	Liver (CYP3A4 enzymes)	Mainly via CYP3A4 and CYP2C9
Excretion	Feces and urine	80% via feces, 13% via urine

Amiodarone: (Moderate) Monitor for an increase in sildenafil-related adverse reactions if coadministration with amiodarone is necessary; consider a starting dose of 25 mg of sildenafil when prescribed for erectile dysfunction.

• Sildenafil citrate’s patent expiration increased market competition.
• Generics help reduce treatment costs globally.
• Pharmaceutical companies conduct clinical trials regularly.
• Safety monitoring continues post-marketing.
• Adverse event reporting is essential for drug safety.
• Patients should only use approved formulations.
• Counterfeit sildenafil products are a concern.
• Purchase from reputable sources is advised.